A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab

por Hummel, Matthew, Bosje, Tjerk, Shaw, Andrew, Liu, Mark Shiyao, Barve, Abhijit, Kothekar, Mudgal, Socinski, Mark A., Waller, Cornelius F.
Publicado 2021

M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study

por Ling, Leona E., Hillson, Jan L., Tiessen, Renger G., Bosje, Tjerk, van Iersel, Mattheus Paulus, Nix, Darrell J., Markowitz, Lynn, Cilfone, Nicholas A., Duffner, Jay, Streisand, James B., Manning, Anthony M., Arroyo, Santiago
Publicado 2018

Implementation and evaluation of an antimicrobial stewardship programme in companion animal clinics: A stepped-wedge design intervention study

por Hopman, Nonke E. M., Portengen, Lützen, Hulscher, Marlies E. J. L., Heederik, Dick J. J., Verheij, T. J. M., Wagenaar, Jaap A., Prins, Jan M., Bosje, Tjerk, Schipper, Louska, van Geijlswijk, Ingeborg M., Broens, Els M.
Publicado 2019